Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Four vials per Carton, Carton contains 2 vials of Thyrogen and 2 vials of diluent, Storage: store at 2-8 C, Genzyme Corporation, Cambridge, MA 02142, NDC 58468-1849-04.
Published March 9, 2016 · Recall initiated: February 16, 2016
Summary
FDA records drug Class II recall D-0729-2016, published March 9, 2016 and initiated February 16, 2016. Recalling firm: Genzyme Corporation; Status: Terminated; Reported quantity: 27,022 vials; Lot: Lot #: E4029Y02 (carton), E4029 (vial) Exp 09/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Glass particles found in the product after reconstitution.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Genzyme Corporation
- Distributor
- Nationwide, Puerto Rico and Malaysia, Taiwan, Brazil, and Israel.
- Lot
- Lot #: E4029Y02 (carton), E4029 (vial) Exp 09/2016
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva PharmachemieNovember 22, 2017
- FDAThyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only,March 9, 2016
- FDACDI H/S Cuvette, non-sterile, Manufactured by Terumo Cardiovascular Group, Perfusion Pack or Smart PerfusionMarch 2, 2016
- FDAEndoVive 3s Low Profile Balloon Kits Part Number: M00549460 (XMD P/N 70-0050-G22) The EndoVive 3s Low ProfileMarch 2, 2016
- FDAseprafilm® Procedure Pack ADHESION BARRIER Re-order Number: 5086-02 Product Usage: Seprafilm Adhesion BarrierJune 27, 2012
- FDAseprafilm® Single Site ADHESION BARRIER Re-order Number: 6641-01 Product Usage: Seprafilm Adhesion Barrier isJune 27, 2012
Questions about this recall
Was Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Four vials per Carton, Carton contains 2 vials of Thyrogen and 2 vials of diluent, Storage: store at 2-8 C, Genzyme Corporation, Cambridge, MA 02142, NDC 58468-1849-04. recalled?
Yes. FDA published recall D-0729-2016 on March 9, 2016. Reported hazard: Presence of Particulate Matter: Glass particles found in the product after reconstitution.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone